Home
News
Create
Screeners
Insights
Fabino Enterprises
19.
35
-19.35
(-100.00%)
Market Cap
₹4.10 Cr
PE Ratio
66.72
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Fabino Enterprises
Fabino Enterprises Ltd. Confirms Non-Applicability of SEBI Large Corporate Framework for FY2027
Apr 11, 2026
Fabino Enterprises Ltd. has disclosed to BSE Limited that it does not fall under SEBI's Large Corporate category as of March 31, 2026, exempting it from filing disclosures under the framework for FY2026-27. The company, formerly known as Fabino Life Sciences Ltd., confirmed its non-applicability status through a formal communication signed by Managing Director Aditya Mahavir Jain on April 11, 2026. The disclosure addresses SEBI's revised framework circular dated October 19, 2023, ensuring regulatory compliance and transparency regarding the company's status.
Fabino Enterprises Ltd. Submits Q4FY26 Compliance Certificate to BSE
Apr 11, 2026
Sushma Shekhar Acquires 8.29% Stake in Fabino Enterprises Through Open Market Purchase
Apr 10, 2026
Fabino Enterprises Independent Director Mr. Kuldeep Solanki Resigns with Immediate Effect
Dec 26, 2025
Fabino Enterprises Appoints Deepali Singla as Independent Director
Dec 26, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO